About this trial
The study aims to evaluate the role of TRUS in improving the efficacy and safety of endoscopic enucleation of prostate and TURP.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Male patients aged 50-80 years
Diagnosed with benign prostatic hyperplasia (BPH) and scheduled for TURP or prostatic adenoma enucleation.
The patients have clear indication for endoscopic surgery (according to the guidelines).
Clinically fit patients for surgery.
Disqualifiers
• Prostate cancer
Previous urethral or prostate surgery
Neurogenic bladder
Urethral stricture
Trial design
Parallel
Treatments tested in this trial
TRUS-Guided TURP and enucleation
Procedure/Surgeryrealtime TRUS guidance during the procedure (TURP and enucleation)
Standard TURP and enucleation
Procedure/SurgeryNo TRUS guidance during the procedure (TURP and enucleation)
Treatment groups
Trial outcomes
Primary outcomes
efficacy of endoscopic treatment of BPH
Intervention efficacy will be evaluated by comparing the Peak flow rate in ml/second.(measured by uroflowmetry) between the two groups
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: